Header Logo

LUDOVICA MARANDO

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
AddressOne Baylor Plaza
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Marando L, Csizmar CM, Patnaik MM. Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovations. Haematologica. 2025 Jan 01; 110(1):22-36. PMID: 39415698; PMCID: PMC11694134.
      Citations:    Fields:    Translation:HumansAnimals
    2. Kusne Y, Badar T, Lasho T, Ferrer A, Mangaonkar AA, Finke C, Marando L, Foran JM, Al-Kali A, Alkhateeb HB, Chlon T, Patnaik MM. Absence of PNH-clones in DDX41mutant-GPS aids in their distinction from acquired BM failure syndromes. Leuk Res. 2024 Oct; 145:107561. PMID: 39182344.
      Citations:    Fields:    Translation:Humans
    3. Isobe T, Kucinski I, Barile M, Wang X, Hannah R, Bastos HP, Chabra S, Vijayabaskar MS, Sturgess KHM, Williams MJ, Giotopoulos G, Marando L, Li J, Rak J, Gozdecka M, Prins D, Shepherd MS, Watcham S, Green AR, Kent DG, Vassiliou GS, Huntly BJP, Wilson NK, G?ttgens B. Preleukemic single-cell landscapes reveal mutation-specific mechanisms and gene programs predictive of AML patient outcomes. Cell Genom. 2023 12 13; 3(12):100426. PMID: 38116120; PMCID: PMC10726426.
      Citations:    
    4. Cheloor Kovilakam S, Gu M, Dunn WG, Marando L, Barcena C, Nik-Zainal S, Mohorianu I, Kar SP, Fabre MA, Quiros PM, Vassiliou GS. Prevalence and significance of DDX41 gene variants in the general population. Blood. 2023 10 05; 142(14):1185-1192. PMID: 37506341.
      Citations:    
    5. Gu M, Kovilakam SC, Dunn WG, Marando L, Barcena C, Mohorianu I, Smith A, Kar SP, Fabre MA, Gerstung M, Cargo CA, Malcovati L, Quiros PM, Vassiliou GS. Author Correction: Multiparameter prediction of myeloid neoplasia risk. Nat Genet. 2023 Oct; 55(10):1777. PMID: 37726541; PMCID: PMC10562208.
      Citations:    
    6. Gu M, Kovilakam SC, Dunn WG, Marando L, Barcena C, Mohorianu I, Smith A, Kar SP, Fabre MA, Gerstung M, Cargo CA, Malcovati L, Quiros PM, Vassiliou GS. Multiparameter prediction of myeloid neoplasia risk. Nat Genet. 2023 09; 55(9):1523-1530. PMID: 37620601; PMCID: PMC10484784.
      Citations:    
    7. Dawson MA, Borthakur G, Huntly BJP, Karadimitris A, Alegre A, Chaidos A, Vogl DT, Pollyea DA, Davies FE, Morgan GJ, Glass JL, Kamdar M, Mateos MV, Tovar N, Yeh P, Delgado RG, Basheer F, Marando L, Gallipoli P, Wyce A, Krishnatry AS, Barbash O, Bakirtzi E, Ferron-Brady G, Karpinich NO, McCabe MT, Foley SW, Horner T, Dhar A, Kremer BE, Dickinson M. A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies. Clin Cancer Res. 2023 02 16; 29(4):711-722. PMID: 36350312; PMCID: PMC9932578.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    8. Meduri E, Breeze C, Marando L, Richardson SE, Huntly BJP. The RNA editing landscape in acute myeloid leukemia reveals associations with disease mutations and clinical outcome. iScience. 2022 Dec 22; 25(12):105622. PMID: 36465109; PMCID: PMC9713371.
      Citations:    
    9. Cummaudo M, Merelli V, De Angelis D, Magli F, Maggioni L, Tambuzzi S, Lanza G, Palazzo C, Colombo A, Lucchesi B, Montedoro P, Agostinelli I, Marognoli M, Marando L, Senatore A, Mazzoni R, Trezzi S, Fornoni C, Torlasco G, Cattaneo C. Institutionalising forensic sciences and medicine in centres for newly arrived unaccompanied minors: A case study from Milano. J Forensic Leg Med. 2022 01; 85:102297. PMID: 34920355.
      Citations:    
    10. Yun H, Narayan N, Vohra S, Giotopoulos G, Mupo A, Madrigal P, Sasca D, Lara-Astiaso D, Horton SJ, Agrawal-Singh S, Meduri E, Basheer F, Marando L, Gozdecka M, Dovey OM, Castillo-Venzor A, Wang X, Gallipoli P, M?ller-Tidow C, Osborne CS, Vassiliou GS, Huntly BJP. Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expression. Nat Genet. 2021 10; 53(10):1443-1455. PMID: 34556857; PMCID: PMC7611829.
      Citations:    
    11. Marando L, Huntly BJP. BETs Need Greens: Folate Deficiency and Resistance to MYC-Targeted Therapies. Cancer Discov. 2020 12; 10(12):1791-1793. PMID: 33262182.
      Citations:    
    12. Forte D, Garc?a-Fern?ndez M, S?nchez-Aguilera A, Stavropoulou V, Fielding C, Mart?n-P?rez D, L?pez JA, Costa ASH, Tronci L, Nikitopoulou E, Barber M, Gallipoli P, Marando L, Fern?ndez de Castillejo CL, Tzankov A, Dietmann S, Cavo M, Catani L, Curti A, V?zquez J, Frezza C, Huntly BJ, Schwaller J, M?ndez-Ferrer S. Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy. Cell Metab. 2020 11 03; 32(5):829-843.e9. PMID: 32966766; PMCID: PMC7658808.
      Citations:    
    13. Marando L, Huntly BJP. Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications. Curr Oncol Rep. 2020 06 01; 22(6):61. PMID: 32476069; PMCID: PMC7261725.
      Citations:    
    14. Basheer F, Giotopoulos G, Meduri E, Yun H, Mazan M, Sasca D, Gallipoli P, Marando L, Gozdecka M, Asby R, Sheppard O, Dudek M, Bullinger L, D?hner H, Dillon R, Freeman S, Ottmann O, Burnett A, Russell N, Papaemmanuil E, Hills R, Campbell P, Vassiliou GS, Huntly BJP. Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML. J Exp Med. 2019 04 01; 216(4):966-981. PMID: 30890554; PMCID: PMC6446874.
      Citations:    
    15. Marando L, Huntly BJP. Hematopoietic stem cells made BETter by inhibition. Haematologica. 2018 06; 103(6):919-921. PMID: 29866885; PMCID: PMC6058785.
      Citations:    
    16. Gallipoli P, Giotopoulos G, Tzelepis K, Costa ASH, Vohra S, Medina-Perez P, Basheer F, Marando L, Di Lisio L, Dias JML, Yun H, Sasca D, Horton SJ, Vassiliou G, Frezza C, Huntly BJP. Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition. Blood. 2018 04 12; 131(15):1639-1653. PMID: 29463564; PMCID: PMC6061932.
      Citations:    
    17. Risitano AM, Imbriaco M, Marando L, Seneca E, Soscia E, Malcovati L, Iori AP, Pane F, Notaro R, Matarazzo M. From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging. Br J Haematol. 2012 Aug; 158(3):415-8. PMID: 22571809.
      Citations:    
    18. Pulini S, Marando L, Natale A, Pascariello C, Catinella V, Del Vecchio L, Risitano AM, Fioritoni G. Paroxysmal nocturnal hemoglobinuria after autologous stem cell transplantation: extinction of the clone during treatment with eculizumab - pathophysiological implications of a unique clinical case. Acta Haematol. 2011; 126(2):103-9. PMID: 21597283.
      Citations:    
    19. Risitano AM, Notaro R, Marando L, Serio B, Ranaldi D, Seneca E, Ricci P, Alfinito F, Camera A, Gianfaldoni G, Amendola A, Boschetti C, Di Bona E, Fratellanza G, Barbano F, Rodeghiero F, Zanella A, Iori AP, Selleri C, Luzzatto L, Rotoli B. Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab. Blood. 2009 Apr 23; 113(17):4094-100. PMID: 19179465.
      Citations:    
    20. Risitano AM, Marando L, Seneca E, Rotoli B. Hemoglobin normalization after splenectomy in a paroxysmal nocturnal hemoglobinuria patient treated by eculizumab. Blood. 2008 Jul 15; 112(2):449-51. PMID: 18606894.
      Citations:    
    MARANDO's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (95)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _